Orbimed Advisors LLC Intellia Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $5.48 Million - $7.38 Million	164,627 New	164,627 $6.14 Million
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $3.1 Million - $6.33 Million	-53,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $7.04 Million - $9.4 Million	53,200 New	53,200 $7.14 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $4.41 Million - $11.7 Million	-72,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $3.38 Million - $6.07 Million	72,500 New	72,500 $5.82 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $2.4 Million - $3.42 Million	-137,100 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $1.39 Million - $2.86 Million	-125,000 Reduced 47.69%	137,100 $2.88 Million
Q4 2019 Feb 14, 2020	SELL	$10.43 - $17.67 $683,165 - $1.16 Million	-65,500 Reduced 19.99%	262,100 $3.85 Million
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $694,000 - $920,500	-50,000 Reduced 13.24%	327,600 $5.36 Million
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $4.18 Million - $9.96 Million	-367,000 Reduced 49.29%	377,600 $5.15 Million
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $3.39 Million - $4.28 Million	-131,400 Reduced 15.0%	744,600 $21.3 Million
Q2 2018 Aug 14, 2018	SELL	$20.02 - $30.79 $4.74 Million - $7.3 Million	-237,000 Reduced 21.29%	876,000 $24 Million
Q1 2018 May 15, 2018	SELL	$19.43 - $34.95 $23.8 Million - $42.8 Million	-1,224,684 Reduced 52.39%	1,113,000 $23.5 Million
Q4 2017 Feb 14, 2018	SELL	$17.39 - $31.12 $5.64 Million - $10.1 Million	-324,496 Reduced 12.19%	2,337,684 $44.9 Million
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $40.4 Million - $68.6 Million	2,662,180	2,662,180 $66.2 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account